Sreekanth MD - CVS HEALTH Executive Officer
| CVS Stock | 14.94 0.27 1.84% |
Executive
Sreekanth MD is Executive Officer of CVS HEALTH CDR
| Age | 44 |
| Address | One CVS Drive, Woonsocket, RI, United States, 02895 |
| Phone | 401 765 1500 |
| Web | https://www.cvshealth.com |
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Matthew Ridgway | Monument Mining Limited | N/A | |
| Terrie Tweddle | Rogers Communications | N/A | |
| Craig Silliman | Verizon Communications CDR | 56 | |
| Charles BSc | Vizsla Silver Corp | 50 | |
| Vandana Venkatesh | Verizon Communications CDR | 51 | |
| MaryLee Stillwell | Verizon Communications CDR | 50 | |
| Kyle Malady | Verizon Communications CDR | 56 | |
| Brady Connor | Verizon Communications CDR | N/A | |
| Marisa Wyse | Rogers Communications | N/A | |
| H Bains | Rogers Communications | N/A | |
| James Gerace | Verizon Communications CDR | 60 | |
| Mark Kennedy | Rogers Communications | N/A | |
| Joseph Russo | Verizon Communications CDR | N/A | |
| Kevin Service | Verizon Communications CDR | N/A | |
| Brandon Tigchelaar | iSign Media Solutions | N/A | |
| Sowmyanarayan Sampath | Verizon Communications CDR | 47 | |
| David Mcarthur | Lion One Metals | N/A | |
| Jennifer Hanson | Vizsla Silver Corp | N/A | |
| Marisa Fabiano | Rogers Communications | N/A | |
| Samantha Hammock | Verizon Communications CDR | 45 | |
| Magda Yrizarry | Verizon Communications CDR | N/A | |
Management Performance
| Return On Equity | 0.067 | ||||
| Return On Asset | 0.0237 |
CVS HEALTH CDR Leadership Team
Elected by the shareholders, the CVS HEALTH's board of directors comprises two types of representatives: CVS HEALTH inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CVS. The board's role is to monitor CVS HEALTH's management team and ensure that shareholders' interests are well served. CVS HEALTH's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CVS HEALTH's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Katerina Guerraz, Chief VP | ||
| Sreekanth MD, Executive Officer | ||
| Vijay Patel, Senior CoFounder | ||
| James Clark, Controller VP | ||
| Prem PharmD, Group President | ||
| David Falkowski, Executive Officer | ||
| FACEP MD, VP Officer | ||
| Laurence McGrath, Senior Relations | ||
| Laurie Havanec, Executive Officer | ||
| David CEBS, Executive Caremark | ||
| Tilak Mandadi, Data, Digital | ||
| Thomas Cowhey, Executive CFO | ||
| Gustavo Giraldo, Head Benefits | ||
| Samrat Esq, Chief VP | ||
| Heidi Capozzi, Executive Officer | ||
| Sheryl Burke, Chief Responsibility | ||
| MPP MD, Senior President | ||
| Karen Lynch, CEO President | ||
| Michelle Peluso, Executive Officer |
CVS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CVS HEALTH a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.067 | ||||
| Return On Asset | 0.0237 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 208.69 B | ||||
| Shares Outstanding | 6.91 B | ||||
| Price To Book | 0.98 X | ||||
| Price To Sales | 0.29 X | ||||
| Revenue | 367.25 B | ||||
| Gross Profit | 53.46 B |
Pair Trading with CVS HEALTH
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CVS HEALTH position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CVS HEALTH will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to CVS HEALTH could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CVS HEALTH when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CVS HEALTH - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CVS HEALTH CDR to buy it.
The correlation of CVS HEALTH is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CVS HEALTH moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CVS HEALTH CDR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CVS HEALTH can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in CVS Stock
CVS HEALTH financial ratios help investors to determine whether CVS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CVS with respect to the benefits of owning CVS HEALTH security.